About: Reverse-transcription polymerase chain reaction/pyrosequencing to characterize neuraminidase H275 residue of influenza A 2009 H1N1 virus for rapid and specific detection of the viral oseltamivir resistance marker in a clinical laboratory

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Reverse-transcription polymerase chain reaction/pyrosequencing to characterize neuraminidase H275 residue of influenza A 2009 H1N1 virus for rapid and specific detection of the viral oseltamivir resistance marker in a clinical laboratory Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Reverse-transcription polymerase chain reaction/pyrosequencing to characterize neuraminidase H275 residue of influenza A 2009 H1N1 virus for rapid and specific detection of the viral oseltamivir resistance marker in a clinical laboratory
Creator	Lewinski, Michael Aleemi, Virginia Bao, Jian Clark, Richard Coon, Stephanie Huard, Thomas Master, Ronald Piscitelli, Arelis Tummala, Praveena
Source	PMC
abstract	Pandemic 2009 H1N1 is normally susceptible to oseltamivir, but variants harboring the H275Y (CAC → TAC) mutation exhibit resistance. We describe the use of a combined reverse-transcription polymerase chain reaction (RT-PCR)/pyrosequencing approach to identify the H275 residue. A total of 223 specimens were tested with this method: 216 randomly selected clinical specimens positive for 2009 H1N1 and 7 cell-culture supernatants from the Centers for Disease Control and Prevention (CDC; 4 resistant, 3 susceptible 2009 H1N1 strains). The assay detected H275Y in 1 clinical respiratory sample (0.5%) and all 4 oseltamivir-resistant strains from the CDC; the remaining 215 clinical and 3 susceptible CDC specimens were wild-type. Sanger sequencing confirmed the results for 50 of 50 selected isolates. The RT-PCR/pyrosequencing method was highly specific, producing no amplicons or valid sequences from samples containing non-H1N1 viruses or bacteria. Our findings suggest that this method provides a rapid tool for H275Y detection, with high sensitivity and potential benefit for patient care.
has issue date	2011-10-13(xsd:dateTime)
bibo:doi	10.1016/j.diagmicrobio.2011.09.003
bibo:pmid	22000086
has license	no-cc
schema:url	https://doi.org/10.1016/j.diagmicrobio.2011.09.003
resource representing a document's title	Reverse-transcription polymerase chain reaction/pyrosequencing to characterize neuraminidase H275 residue of influenza A 2009 H1N1 virus for rapid and specific detection of the viral oseltamivir resistance marker in a clinical laboratory
has PubMed Central identifier	PMC7125974
has PubMed identifier	22000086
schema:publication	Diagn Microbiol Infect Dis
resource representing a document's body	covid:PMC7125974#body_text
is schema:about of	named entity 'neuraminidase' named entity 'OSELTAMIVIR' named entity 'RESIDUE' named entity 'virus' named entity 'neuraminidase' named entity 'oseltamivir' named entity 'clinical laboratory' named entity 'virus' named entity '2009 H1N1' named entity 'oseltamivir' named entity 'mutation' named entity 'antibody' named entity 'OneStep' named entity 'amplicon' named entity 'prednisone' named entity 'Sanger sequencing' named entity 'codon' named entity 'patient specimens' named entity 'real-time PCR' named entity 'WHO' named entity 'virus' named entity 'RNA' named entity 'primers' named entity 'sequenced' named entity 'mutation' named entity 'protein' named entity 'Oseltamivir' named entity 'mutation' named entity 'clinical specimen' named entity 'Sanger sequencing' named entity 'immunocompromised patients' named entity 'thermal cycler' named entity 'Valencia, CA' named entity 'mutation' named entity 'virus' named entity 'virus' named entity 'gene' named entity 'Sanger' named entity 'seasonal influenza' named entity 'GenBank' named entity 'oseltamivir' named entity 'tyrosine' named entity 'viral RNA' named entity '2009 H1N1' named entity 'pyrosequencing' named entity 'oseltamivir' named entity 'TCID50' named entity 'oseltamivir' named entity 'supernatants' named entity 'patient care' named entity '2009 H1N1' named entity 'RNA' named entity '2009 H1N1' named entity 'laboratory safety' named entity 'Sequencher' named entity 'RT-PCR' named entity '2009 H1N1' named entity 'H1N1' named entity 'active site' named entity 'wild-type' named entity 'RT-PCR' named entity 'base calling' named entity 'biosafety' named entity 'pyrosequencing' named entity 'WHO' named entity '2009 H1N1' named entity 'primer' named entity 'Centers for Disease Control and Prevention' named entity 'drug resistance' named entity 'San Diego' named entity 'pyrosequencing' named entity 'TCID50' named entity 'patient care' named entity 'viral RNA'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software